These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 22781793

  • 1. [ITF-2357 on inhibition myeloid leukemic cell lines cells proliferation in vitro and its mechanism].
    Yu WJ, Wang L, You LS, Mei C, Ma QL, Jin J.
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):366-70. PubMed ID: 22781793
    [Abstract] [Full Text] [Related]

  • 2. Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells.
    Barbetti V, Gozzini A, Rovida E, Morandi A, Spinelli E, Fossati G, Mascagni P, Lübbert M, Dello Sbarba P, Santini V.
    Oncogene; 2008 Mar 13; 27(12):1767-78. PubMed ID: 17891169
    [Abstract] [Full Text] [Related]

  • 3. Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell lines.
    Berg T, Guo Y, Abdelkarim M, Fliegauf M, Lübbert M.
    Leuk Res; 2007 Apr 13; 31(4):497-506. PubMed ID: 17056112
    [Abstract] [Full Text] [Related]

  • 4. Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1.
    Tabe Y, Jin L, Contractor R, Gold D, Ruvolo P, Radke S, Xu Y, Tsutusmi-Ishii Y, Miyake K, Miyake N, Kondo S, Ohsaka A, Nagaoka I, Andreeff M, Konopleva M.
    Cell Death Differ; 2007 Aug 13; 14(8):1443-56. PubMed ID: 17464329
    [Abstract] [Full Text] [Related]

  • 5. [The heat shock protein 90 inhibitor induces apoptosis and differentiation of Kasumi-1 and its mechanisms].
    Yu WJ, Rao Q, Wang M, Tian Z, Liu XR, Lin D, Wang JX.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec 13; 26(12):728-31. PubMed ID: 16620576
    [Abstract] [Full Text] [Related]

  • 6. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S, Klisovic RB, Vukosavljevic T, Yu J, Paschka P, Huynh L, Pang J, Neviani P, Liu Z, Blum W, Chan KK, Perrotti D, Marcucci G.
    J Pharmacol Exp Ther; 2007 Jun 13; 321(3):953-60. PubMed ID: 17389244
    [Abstract] [Full Text] [Related]

  • 7. [Effect of phenylbutyrate, a histone deacetylase inhibitor, on differentiation and apoptosis of Kasumi-1 cells].
    Hao CL, Tang KJ, Tian Z, Xing HY, Wang M, Wang JX.
    Zhonghua Xue Ye Xue Za Zhi; 2003 May 13; 24(5):241-4. PubMed ID: 12859874
    [Abstract] [Full Text] [Related]

  • 8. Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells.
    Klisovic MI, Maghraby EA, Parthun MR, Guimond M, Sklenar AR, Whitman SP, Chan KK, Murphy T, Anon J, Archer KJ, Rush LJ, Plass C, Grever MR, Byrd JC, Marcucci G.
    Leukemia; 2003 Feb 13; 17(2):350-8. PubMed ID: 12592335
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia.
    Fu L, Huang W, Jing Y, Jiang M, Zhao Y, Shi J, Huang S, Xue X, Zhang Q, Tang J, Dou L, Wang L, Nervi C, Li Y, Yu L.
    FEBS J; 2014 Feb 13; 281(4):1123-31. PubMed ID: 24314118
    [Abstract] [Full Text] [Related]

  • 12. Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells.
    Barbetti V, Gozzini A, Cheloni G, Marzi I, Fabiani E, Santini V, Dello Sbarba P, Rovida E.
    Epigenetics; 2013 Feb 13; 8(2):210-9. PubMed ID: 23321683
    [Abstract] [Full Text] [Related]

  • 13. Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression.
    Claus R, Fliegauf M, Stock M, Duque JA, Kolanczyk M, Lübbert M.
    J Leukoc Biol; 2006 Dec 13; 80(6):1462-72. PubMed ID: 17000900
    [Abstract] [Full Text] [Related]

  • 14. The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells.
    Golay J, Cuppini L, Leoni F, Micò C, Barbui V, Domenghini M, Lombardi L, Neri A, Barbui AM, Salvi A, Pozzi P, Porro G, Pagani P, Fossati G, Mascagni P, Introna M, Rambaldi A.
    Leukemia; 2007 Sep 13; 21(9):1892-900. PubMed ID: 17637810
    [Abstract] [Full Text] [Related]

  • 15. [Effect of tyrosine kinase inhibitor Imatinib mesylate on proliferation, differentiation and apoptosis of Kasumi-1 leukemia cell line].
    Wang LH, Rao Q, Wang M, Wang JX.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Aug 13; 26(8):449-52. PubMed ID: 16383232
    [Abstract] [Full Text] [Related]

  • 16. Inducible expression of AML1-ETO fusion protein endows leukemic cells with susceptibility to extrinsic and intrinsic apoptosis.
    Lu Y, Xu YB, Yuan TT, Song MG, Lübbert M, Fliegauf M, Chen GQ.
    Leukemia; 2006 Jun 13; 20(6):987-93. PubMed ID: 16598301
    [Abstract] [Full Text] [Related]

  • 17. [Modulation of histone acetylation and induction of apoptosis in SMMC-7721 cells by phenylhexyl isothiocyanate].
    Lai YD, Ma XD, Huang YQ, Xu XN, Wang XZ, Chiao DJ, Liu D.
    Zhonghua Zhong Liu Za Zhi; 2010 Nov 13; 32(11):804-7. PubMed ID: 21223683
    [Abstract] [Full Text] [Related]

  • 18. Valproic acid triggers differentiation and apoptosis in AML1/ETO-positive leukemic cells specifically.
    Zapotocky M, Mejstrikova E, Smetana K, Stary J, Trka J, Starkova J.
    Cancer Lett; 2012 Jun 28; 319(2):144-153. PubMed ID: 22261333
    [Abstract] [Full Text] [Related]

  • 19. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells.
    Wang J, Saunthararajah Y, Redner RL, Liu JM.
    Cancer Res; 1999 Jun 15; 59(12):2766-9. PubMed ID: 10383127
    [Abstract] [Full Text] [Related]

  • 20. Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
    Moldenhauer A, Frank RC, Pinilla-Ibarz J, Holland G, Boccuni P, Scheinberg DA, Salama A, Seeger K, Moore MA, Nimer SD.
    J Leukoc Biol; 2004 Sep 15; 76(3):623-33. PubMed ID: 15197237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.